Eterna Therapeutics Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eterna Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Eterna Therapeutics Inc. Return On Equity for the quarter ending June 30, 2024 was 1.56K %.
  • Eterna Therapeutics Inc. annual Return On Equity for 2023 was -509 %, a 174% decline from 2022.
  • Eterna Therapeutics Inc. annual Return On Equity for 2022 was -185 %, a 52.8% increase from 2021.
  • Eterna Therapeutics Inc. annual Return On Equity for 2021 was -393 %, a 416% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 1.56K +1.83K Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.47K -1.27K -666% Jan 1, 2024 Mar 31, 2024
Q4 2023 -509 -323 -174% Oct 1, 2023 Dec 31, 2023
Q3 2023 -297 -128 -76% Jul 1, 2023 Sep 30, 2023
Q2 2023 -270 +209 +43.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -191 +163 +46% Jan 1, 2023 Mar 31, 2023
Q4 2022 -185 +208 +52.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -169 +269 +61.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -479 -324 -210% Apr 1, 2022 Jun 30, 2022
Q1 2022 -355 -125 -54.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -393 -317 -416% Oct 1, 2021 Dec 31, 2021
Q3 2021 -438 -374 -593% Jul 1, 2021 Sep 30, 2021
Q2 2021 -155 -104 -204% Apr 1, 2021 Jun 30, 2021
Q1 2021 -230 -195 -563% Jan 1, 2021 Mar 31, 2021
Q4 2020 -76.3 -48.5 -174% Oct 1, 2020 Dec 31, 2020
Q3 2020 -63.1 -52.6 -499% Jul 1, 2020 Sep 30, 2020
Q2 2020 -50.9 -49 -2580% Apr 1, 2020 Jun 30, 2020
Q1 2020 -34.6 -32.2 -1335% Jan 1, 2020 Mar 31, 2020
Q4 2019 -27.8 -23.8 -586% Oct 1, 2019 Dec 31, 2019
Q3 2019 -10.6 +5.18 +32.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.9 +21.4 +91.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -2.41 +22.1 +90.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -4.06 +14.3 +77.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -15.7 +0.59 +3.62% Jul 1, 2018 Sep 30, 2018
Q2 2018 -23.3 +5.77 +19.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -24.5 +32 +56.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -18.4 +86.2 +82.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -16.3 +110 +87.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -29 +92.3 +76.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -56.5 +78.4 +58.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -105 +19 +15.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -126 -21.6 -20.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -121 -38.6 -46.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -135 -76.9 -133% Jan 1, 2016 Mar 31, 2016
Q4 2015 -124 -79.7 -181% Oct 1, 2015 Dec 31, 2015
Q3 2015 -104 -71.2 -214% Jul 1, 2015 Sep 30, 2015
Q2 2015 -82.8 -56.1 -210% Apr 1, 2015 Jun 30, 2015
Q1 2015 -58 -41.5 -252% Jan 1, 2015 Mar 31, 2015
Q4 2014 -43.9 -30.5 -227% Oct 1, 2014 Dec 31, 2014
Q3 2014 -33.3 -32.3 -3317% Jul 1, 2014 Sep 30, 2014
Q2 2014 -26.7 -29.6 -1032% Apr 1, 2014 Jun 30, 2014
Q1 2014 -16.5 -12.2 -285% Jan 1, 2014 Mar 31, 2014
Q4 2013 -13.5 -0.19 -1.43% Oct 1, 2013 Dec 31, 2013
Q3 2013 -0.97 +36.4 +97.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 2.86 +52.8 Apr 1, 2013 Jun 30, 2013
Q1 2013 -4.28 +48.7 +91.9% Jan 1, 2013 Mar 31, 2013
Q4 2012 -13.3 Oct 1, 2012 Dec 31, 2012
Q3 2012 -37.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -49.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -53 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.